Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ Adenocarcinoma
Conditions: Gastric Cancer; Gastroesophageal Junction Adenocarcinoma Interventions: Drug: Infigratinib Sponsors: LianBio LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Gastroenterology | Research